EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitMetaanalyseOpen Access · CC BY 4.0

Intramyocardial Stem Cell Transplantation during Coronary Artery Bypass Surgery Safely Improves Cardiac Function: Meta-Analysis of 20 Randomized Clinical Trials

Tri Wisesa Soetisna iD, Ahmad Muslim Hidayat Thamrin, Diajeng Permadijana iD, Andi Nurul Erisya Ramadhani, Sugisman, Anwar Santoso, Muchtaruddin Mansyur iD

Journal of Clinical Medicine · 30.06.2023 · 12 (13) · 4430

DOI: 10.3390/jcm12134430 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 30.06.2023. Verfasst von Tri Wisesa Soetisna und 6 weiteren Autor:innen. Beteiligte Einrichtung: Adult Cardiac Surgery Division, Department of Thoracic and Cardiovascular Surgery, Harapan Kita National Cardiovascular Center Hospital, Jakarta 1142…. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IMSC transplantation during CABG is considered one of the most promising methods to effectively deliver stem cells and has been widely studied in many trials. But the results of outcomes and safety of this modality still vary widely. We conducted this meta-analysis of randomized controlled trials (RCTs) to evaluate not only the outcome but also the safety of this promising method. A meta-analysis was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. A comprehensive literature search was undertaken using the PubMed, Scopus, and Cochrane databases. Articles were thoroughly evaluated and analyzed. Twenty publications about IMSC during CABG were included. Primary outcomes were measured using LVEF, LVESV, LVESVI, LVESD, LVEDV, LVEDVI, LVEDD, WMSI, and 6-MWT. Safety measures were depicted by total deaths, MACE, CRD, CVA, myocardial infarction, ventricular arrhythmia, and cardiac-related readmission. IMSC transplantation during CABG significantly improved LVEF (MD = 3.89%; 95% CI = 1.31% to 6.46%; p = 0.003) and WMSI (MD = 0.28; 95% CI = 0.01–0.56; p = 0.04). Most of the other outcomes showed favorable results for the IMSC group but were not statistically significant. The safety analysis also showed no significant risk difference for IMSC transplantation compared to CABG alone. IMSC during CABG can safely improve cardiac function and tend to improve cardiac volumes and dimensions. The analysis and application of influencing factors that increase patients’ responses to IMSC transplantation are important to achieve long-term improvement.

Schlagwörter

Stichwörter der Autor:innen

coronary artery bypassintramyocardialischemic heart diseaseoutcomesafetystem cell

Autor:innen und Institutionen

  • Adult Cardiac Surgery Division, Department of Thoracic and Cardiovascular Surgery, Harapan Kita National Cardiovascular Center Hospital, Jakarta 11420, Indonesia.
  • Department of Thoracic and Cardiovascular Surgery, Faculty of Medicine, University of Indonesia, Jakarta 10430, Indonesia.
  • Faculty of Medicine, Syarif Hidayatullah State Islamic University, Haji Hospital, Jakarta 13560, Indonesia.
  • Department of Cardiology and Vascular Medicine, Harapan Kita National Cardiovascular Center Hospital, Jakarta 11420, Indonesia.
  • Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, Jakarta 10430, Indonesia.
  • Department of Community Medicine, Faculty of Medicine, University of Indonesia, Jakarta 10430, Indonesia.

ORCID-Profile: Tri Wisesa Soetisna, Diajeng Permadijana, Muchtaruddin Mansyur

Zitieren

APA

Soetisna, T. W., Thamrin, A. M. H., Permadijana, D., Ramadhani, A. N. E., Sugisman, Santoso, A., & Mansyur, M. (2023). Intramyocardial Stem Cell Transplantation during Coronary Artery Bypass Surgery Safely Improves Cardiac Function: Meta-Analysis of 20 Randomized Clinical Trials. Journal of Clinical Medicine, 12(13), 4430. https://doi.org/10.3390/jcm12134430

Vancouver

Soetisna TW, Thamrin AMH, Permadijana D, Ramadhani ANE, Sugisman, Santoso A, et al. Intramyocardial Stem Cell Transplantation during Coronary Artery Bypass Surgery Safely Improves Cardiac Function: Meta-Analysis of 20 Randomized Clinical Trials. Journal of Clinical Medicine. 2023;12(13):4430. doi:10.3390/jcm12134430

BibTeX
@article{Soetisna2023,
  author = {Soetisna, Tri Wisesa and Thamrin, Ahmad Muslim Hidayat and Permadijana, Diajeng and Ramadhani, Andi Nurul Erisya and Sugisman and Santoso, Anwar and Mansyur, Muchtaruddin},
  title = {Intramyocardial Stem Cell Transplantation during Coronary Artery Bypass Surgery Safely Improves Cardiac Function: Meta-Analysis of 20 Randomized Clinical Trials},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {13},
  pages = {4430},
  doi = {10.3390/jcm12134430}
}
Kostenlos starten →